台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

櫻華企業股份有限公司 嘉義巿啟明路３４號 - l-isoleucine;;l-leucine;;lysine hcl;;l-methionine;;l-phenylalanine;;l-threonine;;l-tryptophan;;l-valine;;glycine (eq to aminoacetic acid)(eq to glycocoll);;arginine hcl l-;;histidine l- hcl (eq to l-histidine hydrochloride) - 注射劑 - arginine hcl l- (4020100312) 8.00mg; histidine l- hcl (eq to l-histidine hydrochloride) (4020100912) 4.00mg; l-isoleucine (4020101002) 5.50mg; l-leucine (4020101202) 12.30mg; lysine hcl (4020101310) 22.30mg; l-methionine (4020101502) 7.10mg; l-phenylalanine (4020101702) 8.70mg; l-threonine (4020102002) 5.40mg; l-tryptophan (4020102102) 1.80mg; l-valine (4020102302) 6.10mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) 10.00mg - 不能攝取適當食物之患者之補助治療劑、蛋白質之消化吸收機能及合成利用障礙、嚴重創傷、火傷、骨折時蛋白質之補給、蛋白質攝取減少之營養失調症

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

僑泰興業股份有限公司 台北巿民權東路六段３１０號２樓 (11858509) - glycine (eq to aminoacetic acid)(eq to glycocoll);;lysine hcl;;l-isoleucine;;l-methionine;;l-phenylalanine;;l-threonine;;l-tryptophan;;l-valine;;l-leucine;;arginine hcl l-;;histidine l- hcl (eq to l-histidine hydrochloride);;glutamic acid l-;;cystine l-;;aspartic acid;;l-alanine;;l-proline;;l-serine;;l-tyrosine;;xylitol - 注射劑 - xylitol (4020001900) 50.00mg; l-alanine (4020100202) 8.21mg; arginine hcl l- (4020100312) 14.88mg; aspartic acid (4020100400) 2.02mg; cystine l- (4020100602) 0.23mg; glutamic acid l- (4020100702) 1.02mg; histidine l- hcl (eq to l-histidine hydrochloride) (4020100912) 7.06mg; l-isoleucine (4020101002) 5.97mg; l-leucine (4020101202) 11.38mg; lysine hcl (4020101310) 9.80mg; l-methionine (4020101502) 4.33mg; l-phenylalanine (4020101702) 9.47mg; l-proline (4020101802) 10.63mg; l-serine (4020101902) 4.67mg; l-threonine (4020102002) 5.04mg; l-tryptophan (4020102102) 1.87mg; l-tyrosine (4020102202) 0.57mg; l-valine (4020102302) 6.90mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) 15.68mg - 手術前後之營養補給、低蛋白血症、消化潰瘍營養障礙之補給

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

僑泰興業股份有限公司 台北巿民權東路六段３１０號２樓 (11858509) - glycine (eq to aminoacetic acid)(eq to glycocoll);;lysine hcl;;l-isoleucine;;l-methionine;;l-phenylalanine;;l-threonine;;l-tryptophan;;l-valine;;l-leucine;;arginine hcl l-;;histidine l- hcl (eq to l-histidine hydrochloride);;glutamic acid l-;;cystine l-;;aspartic acid;;l-alanine;;l-proline;;l-serine;;l-tyrosine;;xylitol - 注射劑 - xylitol (4020001900) 50mg; l-alanine (4020100202) 2.17mg; arginine hcl l- (4020100312) 3.93mg; aspartic acid (4020100400) 0.53mg; cystine l- (4020100602) 0.06mg; glutamic acid l- (4020100702) 0.27mg; histidine l- hcl (eq to l-histidine hydrochloride) (4020100912) 1.87mg; l-isoleucine (4020101002) 1.58mg; l-leucine (4020101202) 3.01mg; lysine hcl (4020101310) 2.59mg; l-methionine (4020101502) 1.14mg; l-phenylalanine (4020101702) 2.57mg; l-proline (4020101802) 2.81mg; l-serine (4020101902) 1.23mg; l-threonine (4020102002) 1.33mg; l-tryptophan (4020102102) 0.49mg; l-tyrosine (4020102202) 0.15mg; l-valine (4020102302) 1.82mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) 4.14mg - 手術前後之營養補給、低蛋白血症、消化道潰瘍、營養障礙之補給

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

羅氏大藥廠股份有限公司 台北市信義區松仁路100號40樓、40樓之1、41樓之1 (23167467) - polatuzumab vedotin;;polatuzumab vedotin - 凍晶注射劑 - polatuzumab vedotin (1013007700) mg; polatuzumab vedotin (1013007700) mg - polatuzumab vedotin - 1.與rituximab、cyclophosphamide、doxorubicin和prednisone (r-chp)併用，適用於治療先前未接受過治療之瀰漫性大型b細胞淋巴瘤(dlbcl)成人病人。2.與bendamustine和rituximab併用，適用於治療復發型(relapsed)或難治型(refractory)且不適合接受造血幹細胞移植的瀰漫性大型b細胞淋巴瘤(dlbcl)病人。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

和聯生技藥業股份有限公司 臺北市松山區敦化北路311號5樓 (04270075) - thiotepa;;thiotepa - 凍晶注射劑 - thiotepa (1004003000) mg; thiotepa (1004003000) mg - thiotepa - 適用於合併其他化療藥物：• 可合併或不合併全身放射治療(tbi)，作為成人與兒童血液疾病病人進行異體或自體造血前驅細胞移植(haematopoietic progenitor cell transplantation，hpct)前之調適治療(conditioning regimen)；• 使用於當兒童病人適合以高劑量化療合併造血前驅細胞移植hpct的支持療法作為實體腫瘤治療時。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

厚星有限公司 嘉義巿仁和里興中街１３９號１樓 (23782049) - glycine (eq to aminoacetic acid)(eq to glycocoll);;lysine hcl;;l-isoleucine;;l-methionine;;l-phenylalanine;;l-threonine;;l-tryptophan;;l-valine;;l-leucine;;arginine hcl l-;;histidine l- hcl (eq to l-histidine hydrochloride);;glutamic acid l-;;cystine l-;;l-aspartic acid;;l-alanine;;l-proline;;l-serine;;l-tyrosine - 注射劑 - l-alanine (4020100202) 821mg; arginine hcl l- (4020100312) 1488mg; l-aspartic acid (4020100402) 202mg; cystine l- (4020100602) 23mg; glutamic acid l- (4020100702) 102mg; histidine l- hcl (eq to l-histidine hydrochloride) (4020100912) 706mg; l-isoleucine (4020101002) 597mg; l-leucine (4020101202) 1138mg; lysine hcl (4020101310) 980mg; l-methionine (4020101502) 433mg; l-phenylalanine (4020101702) 947mg; l-proline (4020101802) 1063mg; l-serine (4020101902) 467mg; l-threonine (4020102002) 504mg; l-tryptophan (4020102102) 187mg; l-tyrosine (4020102202) 57mg; l-valine (4020102302) 690mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) 1568mg - 不能攝取適當食物之患者之補助治療劑、蛋白質之消化吸收機能及合成利用障礙、嚴重創傷、火傷、骨折時蛋白質之補給、蛋白質攝取減少之營養失調症